What
We Do: WaveSense develops, manufactures, and markets
breakthrough analytical nanotechnologies for use in cellular and
molecular assay markets. Some of the applications that we are
actively engaged in consist of drug discovery, rare cell detection
in blood and bone marrow, nucleic acid tests for infectious disease,
bio-defense, veterinary diagnostics, and regenerative medicine.
Our Proprietary Technology:
Our patented and hierarchy technology is called Xenographic Retention
Chromatography™ (XRC) - branded as EpiSep™, which
is a lateral flow separations platform that provides rapid, advanced
detection and characterization of live cells, proteins, and/or
genes. Researchers can then harvest the targets for interrogation
purposes within their desired application.
Our Value Proposition:
We developed EpiSep™ because current assays that detect
rare targets are outgrowing the capabilities and efficiencies
of platforms that are commonly used to perform these tests. Our
EpiSep™ platform, and extensive line of leading-edge assays,
are revolutionary to the analytical industry as they fulfill a
critical demand to significantly improve test sensitivity and
workflow procedures, while reducing operational costs and complexity.
Users of Our Products:
End users of our products consist of reference laboratories, pathologists,
and researchers that perform a wide variety of analytical tests
for research purposes.
Why We Do This:
We strive to improve the quality and length of life by discovering
and applying leading-edge nanotechnologies to life science research.
We adopt this approach with an added interest to create value
for our employees and shareholders.
Our Background:
WaveSense is a privately held California company that was founded
in 1999 by Christopher Feistel and Robert Coleman. Individually
and collectively, Feistel and Coleman have participated as principal
inventor, co-founder, chairman, president and/or CEO of more than
10 medical device companies resulting in successful organizations
with combined valuations exceeding one billion dollars.
Our Facility
- Our corporate offices and laboratory are housed in an
8500 Square Foot facility located at 15339 Barranca Parkway, Irvine,
CA 92618.
Thank you for visiting our web site.
|
